Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma by A P Dubey, Sameer Khatri, Sachin Maggo, Nilabh K Singh, Durgesh Sharma

Subjects: Get full text

Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world data by Ning Lyu, Zahra Majd, Bilqees Fatima, Zhen Zeng, Hua Chen, Susan Abughosh

Subjects: “…Relapsed/refractory…”
Get full text

Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM) by Josip Batinić, Barbara Dreta, Goran Rinčić, Antonia Mrdeža, Karla Mišura Jakobac, Delfa Radić Krišto, Milan Vujčić, Mario Piršić, Željko Jonjić, Vlatka Periša, Jasminka Sinčić Petričević, Božena Coha, Hrvoje Holik, Toni Valković, Marija Stanić, Ivan Krečak, Ante Stojanović, Domagoj Sajfert, Sandra Bašić-Kinda

Subjects: Get full text

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group by Jiri Minarik, Ludek Pour, Vojtech Latal, Tomas Jelinek, Jan Straub, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Martin Stork, Tomas Pika, Petra Krhovska, Tereza Popkova, Frantisek Sedlak, Ivan Spicka, Pavel Jindra, Vladimira Capounova, Vladimir Maisnar, Roman Hajek

Subjects: Get full text

Real-World Treatment Patterns and Survival Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with a Selinexor-Containing Triplet-Based Regimen by Andrew Whiteley, Stephen C. Ijioma, David Ray, Spencer S. Langerman, Ellen Hu, Amy Pierre, Tomer Mark, Habte Yimer

Subjects: Get full text

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center by Ziyi Hao, Yingying Fei, Juan Chen, Sailan Huang, Li Wang, Youhuan Yu, Meiru Bian, Yejun Si, Xingxia Zhang, Xiaotian Yang, Bing Zhang, Yan Wan, Guoqiang Lin, Yanming Zhang

Subjects: “…relapsed/refractory B-ALL…”
Get full text

Gilteritinib by Harini Raghunathan, Parathan Karunakaran

Subjects: Get full text

Bortezomib, Mitoxantrone Hydrochloride Liposome, and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Multi‐Center, Open‐Label Phase I Trial by Ya‐Lan Zhou, Jin‐Qiao Zhang, Wei Wang, Li Bao, Bai‐Jun Fang, Da Gao, Li‐Ping Su, Wen‐Ming Chen, Guang‐Zhong Yang

Subjects: Get full text

Updates in novel immunotherapeutic strategies for relapsed/refractory AML by Sawyer Bawek, Sawyer Bawek, Sayuri Gurusinghe, Matthew Burwinkel, Amanda Przespolewski, Amanda Przespolewski

Subjects: Get full text

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region... by Ayman Alhejazi, Ahmad Alhuraiji, Abdulnaser Nourallah, Abdulrahman Alshehri, Binyam Usman, Ghada ElGohary, Hafiz Malhan, Ibraheem Motabi, Ibraheem Motabi, Khalil Al Farsi, Mohammed Alshuaibi, Mohanad Diab, Mustaqeem Siddiqui, Ruba Yasin Taha, Tarek Abouzeid, Wesam Ahmed, Wesam Ahmed, Ahmed Ramadan Ali, Rasha Ghonema, Sana Faysal Elkhazin, Yousra Moussa, Abdullah M. Alrajhi, Abdullah M. Alrajhi, Magdy Rabea, Yahia Aktham, Nesreen Bawazeer, Ali Ahmed Ali, Mohamed Zahir Chouikrat

Subjects: Get full text

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma by Barry Paul, Jiri Minarik, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Usmani, Mei Dong, Lin Gu, Carmen Leung, Parul Doshi, Christine Chen, Ludek Pour

Subjects: Get full text

CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA by Ugo Testa, Elvira Pelosi, Germana Castelli, Alberto Fresa, Luca Laurenti

Subjects: “…CAR-T Cells; CLL relapsed/refractory…”
Get full text

The impact of antibiotic use on outcomes of relapsed/refractory multiple myeloma patients treated with CAR-T therapy by Lingling Yin, Lingling Yin, Lingling Yin, Bin Lv, Bin Lv, Jiao Ge, Yuekun Qi, Yuekun Qi, Yuekun Qi, Jieyun Xia, Jieyun Xia, Jieyun Xia, Sha Ma, Sha Ma, Sha Ma, Ying Wang, Ying Wang, Ying Wang, Yang Liu, Yang Liu, Yang Liu, Dian Zhou, Dian Zhou, Dian Zhou, Jiang Cao, Jiang Cao, Jiang Cao, Zhiling Yan, Zhiling Yan, Zhiling Yan, Kunming Qi, Kunming Qi, Kunming Qi, Wei Sang, Wei Sang, Wei Sang, Depeng Li, Depeng Li, Depeng Li, Hai Cheng, Hai Cheng, Hai Cheng, Wei Chen, Wei Chen, Wei Chen, Kailin Xu, Kailin Xu, Kailin Xu, Weiying Gu, Zhenyu Li, Zhenyu Li, Zhenyu Li, Feng Zhu, Feng Zhu, Feng Zhu

Subjects: Get full text

Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations by Bhavana Bhatnagar, Daelynn R. Buelow, Kaitlyn M. Dvorak-Kornaus, Shelley J. Orwick, Jae Yoon Jeon, Zahra Talebi, Amy S. Ruppert, James S. Blachly, Uma Borate, Sharyn D. Baker

Subjects: Get full text

Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL by Gaoxiang Wang, Meijuan Huang, Lijun Jiang, Xiaoying Zhang, Zhenhao Wang, Qiuxia Yu, Dengju Li, Yang Yang, Xin Yang, Yang Cao

Subjects: Get full text

Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in Taiwan by Chieh-Lin Jerry Teng, Su-Peng Yeh, Tsai-Yun Chen, Yu-Chin Hung, Yun-Chu Lin, Sin Syue Li, Ming-Chung Wang, Shang-Yi Huang

Subjects: Get full text

Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review by Hongjuan Dong, Rui Wang, Lu Cheng, Shirong Ma, Li Zhu, Jing Zhao, Guangxun Gao

Subjects: Get full text

Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma by Maria Cristina Pirosa, Anastasios Stathis, Emanuele Zucca

Subjects: Get full text

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review by Francesca Gay, Francesca Gay, Elena Zamagni, Elena Zamagni, Craig Emmitt Cole, Craig Emmitt Cole, Christof Scheid, Malin Hultcrantz, Justyna Chorazy, Ike Iheanacho, Anuja Pandey, Jacopo Bitetti, Natalie Boytsov, Molly Purser, Simon McNamara, Shinsuke Iida

Subjects: Get full text

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study by Yan Wang, Chun Chang, Zhen Wang, Jie Zhao, Jingbo Wang

Subjects: Get full text